CA2908443A1 - Blastoid, cell line based artificial blastocyst - Google Patents
Blastoid, cell line based artificial blastocystInfo
- Publication number
- CA2908443A1 CA2908443A1 CA2908443A CA2908443A CA2908443A1 CA 2908443 A1 CA2908443 A1 CA 2908443A1 CA 2908443 A CA2908443 A CA 2908443A CA 2908443 A CA2908443 A CA 2908443A CA 2908443 A1 CA2908443 A1 CA 2908443A1
- Authority
- CA
- Canada
- Prior art keywords
- cell
- cells
- pathway
- blastoid
- aggregate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000002459 blastocyst Anatomy 0.000 title abstract description 76
- 210000004027 cell Anatomy 0.000 claims abstract description 648
- 230000037361 pathway Effects 0.000 claims abstract description 167
- 238000000034 method Methods 0.000 claims abstract description 97
- 210000002993 trophoblast Anatomy 0.000 claims abstract description 83
- 210000000130 stem cell Anatomy 0.000 claims abstract description 48
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 claims abstract description 40
- 102000043136 MAP kinase family Human genes 0.000 claims abstract description 39
- 108091054455 MAP kinase family Proteins 0.000 claims abstract description 39
- 108091008611 Protein Kinase B Proteins 0.000 claims abstract description 39
- 108050003627 Wnt Proteins 0.000 claims abstract description 37
- 102000013814 Wnt Human genes 0.000 claims abstract description 37
- 238000012258 culturing Methods 0.000 claims abstract description 36
- 102000003923 Protein Kinase C Human genes 0.000 claims abstract description 34
- 108090000315 Protein Kinase C Proteins 0.000 claims abstract description 34
- 239000003112 inhibitor Substances 0.000 claims abstract description 29
- 239000011435 rock Substances 0.000 claims abstract description 27
- 230000004655 Hippo pathway Effects 0.000 claims abstract description 26
- 101000617830 Homo sapiens Sterol O-acyltransferase 1 Proteins 0.000 claims abstract description 25
- 102100021993 Sterol O-acyltransferase 1 Human genes 0.000 claims abstract description 25
- 101000697584 Streptomyces lavendulae Streptothricin acetyltransferase Proteins 0.000 claims abstract description 25
- 210000001671 embryonic stem cell Anatomy 0.000 claims description 84
- 230000004913 activation Effects 0.000 claims description 53
- 238000000338 in vitro Methods 0.000 claims description 50
- 239000001963 growth medium Substances 0.000 claims description 39
- 210000001161 mammalian embryo Anatomy 0.000 claims description 39
- 239000012190 activator Substances 0.000 claims description 27
- 238000012239 gene modification Methods 0.000 claims description 26
- 230000005017 genetic modification Effects 0.000 claims description 26
- 235000013617 genetically modified food Nutrition 0.000 claims description 26
- 230000001464 adherent effect Effects 0.000 claims description 23
- 210000004291 uterus Anatomy 0.000 claims description 21
- 230000019491 signal transduction Effects 0.000 claims description 14
- 238000004113 cell culture Methods 0.000 claims description 9
- 102000001267 GSK3 Human genes 0.000 claims description 6
- 108060006662 GSK3 Proteins 0.000 claims description 6
- NFVJNJQRWPQVOA-UHFFFAOYSA-N n-[2-chloro-5-(trifluoromethyl)phenyl]-2-[3-(4-ethyl-5-ethylsulfanyl-1,2,4-triazol-3-yl)piperidin-1-yl]acetamide Chemical compound CCN1C(SCC)=NN=C1C1CN(CC(=O)NC=2C(=CC=C(C=2)C(F)(F)F)Cl)CCC1 NFVJNJQRWPQVOA-UHFFFAOYSA-N 0.000 claims description 6
- 230000023895 stem cell maintenance Effects 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 210000002966 serum Anatomy 0.000 claims description 2
- 102000038624 GSKs Human genes 0.000 claims 1
- 108091007911 GSKs Proteins 0.000 claims 1
- FABQUVYDAXWUQP-UHFFFAOYSA-N N4-(1,3-benzodioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine Chemical compound COC1=CC=CC(C=2N=C(N)N=C(NCC=3C=C4OCOC4=CC=3)C=2)=C1 FABQUVYDAXWUQP-UHFFFAOYSA-N 0.000 claims 1
- 229940043355 kinase inhibitor Drugs 0.000 claims 1
- 239000003757 phosphotransferase inhibitor Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 68
- 241001465754 Metazoa Species 0.000 abstract description 50
- 150000001875 compounds Chemical class 0.000 abstract description 18
- 210000001778 pluripotent stem cell Anatomy 0.000 abstract description 17
- 210000004952 blastocoel Anatomy 0.000 abstract description 11
- 210000003754 fetus Anatomy 0.000 abstract description 5
- 238000012606 in vitro cell culture Methods 0.000 abstract description 3
- 210000004263 induced pluripotent stem cell Anatomy 0.000 abstract description 3
- 210000001519 tissue Anatomy 0.000 description 60
- 239000002609 medium Substances 0.000 description 55
- 239000010410 layer Substances 0.000 description 45
- 210000002257 embryonic structure Anatomy 0.000 description 38
- 230000014509 gene expression Effects 0.000 description 36
- 108090000623 proteins and genes Proteins 0.000 description 28
- 102100027609 Rho-related GTP-binding protein RhoD Human genes 0.000 description 26
- 108010083123 CDX2 Transcription Factor Proteins 0.000 description 24
- 102000006277 CDX2 Transcription Factor Human genes 0.000 description 24
- 239000003446 ligand Substances 0.000 description 24
- 230000004069 differentiation Effects 0.000 description 21
- 230000002068 genetic effect Effects 0.000 description 20
- 102000004169 proteins and genes Human genes 0.000 description 20
- 238000011161 development Methods 0.000 description 19
- 230000001105 regulatory effect Effects 0.000 description 19
- 241000894007 species Species 0.000 description 19
- AQGNHMOJWBZFQQ-UHFFFAOYSA-N CT 99021 Chemical compound CC1=CNC(C=2C(=NC(NCCNC=3N=CC(=CC=3)C#N)=NC=2)C=2C(=CC(Cl)=CC=2)Cl)=N1 AQGNHMOJWBZFQQ-UHFFFAOYSA-N 0.000 description 18
- 230000011664 signaling Effects 0.000 description 18
- 108090000381 Fibroblast growth factor 4 Proteins 0.000 description 17
- 208000035199 Tetraploidy Diseases 0.000 description 17
- 230000018109 developmental process Effects 0.000 description 17
- 238000010899 nucleation Methods 0.000 description 16
- 102000003969 Fibroblast growth factor 4 Human genes 0.000 description 15
- 101001076292 Homo sapiens Insulin-like growth factor II Proteins 0.000 description 15
- 230000008901 benefit Effects 0.000 description 15
- 210000001654 germ layer Anatomy 0.000 description 15
- 229940068935 insulin-like growth factor 2 Drugs 0.000 description 15
- 210000000472 morula Anatomy 0.000 description 15
- 102100025947 Insulin-like growth factor II Human genes 0.000 description 14
- 230000001413 cellular effect Effects 0.000 description 14
- 238000001727 in vivo Methods 0.000 description 14
- 230000005764 inhibitory process Effects 0.000 description 14
- 210000004940 nucleus Anatomy 0.000 description 14
- 239000000126 substance Substances 0.000 description 14
- IYOZTVGMEWJPKR-VOMCLLRMSA-N 4-[(1R)-1-aminoethyl]-N-pyridin-4-yl-1-cyclohexanecarboxamide Chemical compound C1CC([C@H](N)C)CCC1C(=O)NC1=CC=NC=C1 IYOZTVGMEWJPKR-VOMCLLRMSA-N 0.000 description 13
- 241000124008 Mammalia Species 0.000 description 13
- 102000040945 Transcription factor Human genes 0.000 description 12
- 108091023040 Transcription factor Proteins 0.000 description 12
- 239000006143 cell culture medium Substances 0.000 description 12
- 210000001900 endoderm Anatomy 0.000 description 12
- 238000003306 harvesting Methods 0.000 description 12
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 description 11
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 11
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 11
- 102100033762 Proheparin-binding EGF-like growth factor Human genes 0.000 description 11
- 230000004720 fertilization Effects 0.000 description 11
- 102000005962 receptors Human genes 0.000 description 11
- 108020003175 receptors Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 239000003102 growth factor Substances 0.000 description 10
- 238000011160 research Methods 0.000 description 10
- LUZOFMGZMUZSSK-LRDDRELGSA-N (-)-indolactam V Chemical compound C1[C@@H](CO)NC(=O)[C@H](C(C)C)N(C)C2=CC=CC3=C2C1=CN3 LUZOFMGZMUZSSK-LRDDRELGSA-N 0.000 description 9
- 239000012909 foetal bovine serum Substances 0.000 description 9
- 230000012010 growth Effects 0.000 description 9
- 238000003365 immunocytochemistry Methods 0.000 description 9
- 230000001939 inductive effect Effects 0.000 description 9
- 230000026731 phosphorylation Effects 0.000 description 9
- 238000006366 phosphorylation reaction Methods 0.000 description 9
- 210000002826 placenta Anatomy 0.000 description 9
- 108091006146 Channels Proteins 0.000 description 8
- LUZOFMGZMUZSSK-UHFFFAOYSA-N Indolactam-V Natural products C1C(CO)NC(=O)C(C(C)C)N(C)C2=CC=CC3=C2C1=CN3 LUZOFMGZMUZSSK-UHFFFAOYSA-N 0.000 description 8
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 8
- 229930182816 L-glutamine Natural products 0.000 description 8
- 108090000581 Leukemia inhibitory factor Proteins 0.000 description 8
- 230000027455 binding Effects 0.000 description 8
- 230000024245 cell differentiation Effects 0.000 description 8
- 230000008668 cellular reprogramming Effects 0.000 description 8
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 8
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 7
- 101000819111 Homo sapiens Trans-acting T-cell-specific transcription factor GATA-3 Proteins 0.000 description 7
- 101100445364 Mus musculus Eomes gene Proteins 0.000 description 7
- 239000004793 Polystyrene Substances 0.000 description 7
- 102100021386 Trans-acting T-cell-specific transcription factor GATA-3 Human genes 0.000 description 7
- 102000046299 Transforming Growth Factor beta1 Human genes 0.000 description 7
- 101800002279 Transforming growth factor beta-1 Proteins 0.000 description 7
- 101100445365 Xenopus laevis eomes gene Proteins 0.000 description 7
- 210000001647 gastrula Anatomy 0.000 description 7
- 229920002223 polystyrene Polymers 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 229940099456 transforming growth factor beta 1 Drugs 0.000 description 7
- 238000001262 western blot Methods 0.000 description 7
- 229920000936 Agarose Polymers 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- 108010009583 Transforming Growth Factors Proteins 0.000 description 6
- 102000009618 Transforming Growth Factors Human genes 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 210000002308 embryonic cell Anatomy 0.000 description 6
- 229960005309 estradiol Drugs 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 238000002513 implantation Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 210000000056 organ Anatomy 0.000 description 6
- 230000008520 organization Effects 0.000 description 6
- 238000003752 polymerase chain reaction Methods 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 231100000419 toxicity Toxicity 0.000 description 6
- 230000001988 toxicity Effects 0.000 description 6
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 6
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 5
- 108010059616 Activins Proteins 0.000 description 5
- 102100025051 Cell division control protein 42 homolog Human genes 0.000 description 5
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 5
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
- 102100026818 Inhibin beta E chain Human genes 0.000 description 5
- 101100310648 Mus musculus Sox17 gene Proteins 0.000 description 5
- 101150000629 TGFB1 gene Proteins 0.000 description 5
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 5
- 239000000488 activin Substances 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 230000005754 cellular signaling Effects 0.000 description 5
- 229930182833 estradiol Natural products 0.000 description 5
- 239000005090 green fluorescent protein Substances 0.000 description 5
- 230000005283 ground state Effects 0.000 description 5
- 210000003783 haploid cell Anatomy 0.000 description 5
- 230000035755 proliferation Effects 0.000 description 5
- 108091008598 receptor tyrosine kinases Proteins 0.000 description 5
- 102000027426 receptor tyrosine kinases Human genes 0.000 description 5
- 230000035897 transcription Effects 0.000 description 5
- 238000013518 transcription Methods 0.000 description 5
- 230000035899 viability Effects 0.000 description 5
- 108010085238 Actins Proteins 0.000 description 4
- 102000007469 Actins Human genes 0.000 description 4
- 108010007726 Bone Morphogenetic Proteins Proteins 0.000 description 4
- 102000007350 Bone Morphogenetic Proteins Human genes 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 4
- VHSVKVWHYFBIFJ-HKZYLEAXSA-N G-1 Chemical compound C1=C(Br)C([C@@H]2NC3=CC=C(C=C3[C@@H]3C=CC[C@@H]32)C(=O)C)=CC2=C1OCO2 VHSVKVWHYFBIFJ-HKZYLEAXSA-N 0.000 description 4
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 4
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 4
- 102100023328 G-protein coupled estrogen receptor 1 Human genes 0.000 description 4
- 101000829902 Homo sapiens G-protein coupled estrogen receptor 1 Proteins 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 4
- 102000004058 Leukemia inhibitory factor Human genes 0.000 description 4
- 102100032352 Leukemia inhibitory factor Human genes 0.000 description 4
- 101100490443 Mus musculus Acvr1 gene Proteins 0.000 description 4
- 101000653007 Mus musculus Thromboxane-A synthase Proteins 0.000 description 4
- 101000608785 Mus musculus Thymidylate synthase Proteins 0.000 description 4
- 101150038994 PDGFRA gene Proteins 0.000 description 4
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 description 4
- 230000003213 activating effect Effects 0.000 description 4
- 230000002457 bidirectional effect Effects 0.000 description 4
- 229940112869 bone morphogenetic protein Drugs 0.000 description 4
- 210000001840 diploid cell Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000002242 embryoid body Anatomy 0.000 description 4
- 231100000994 embryonic stem cell test for embryotoxicity Toxicity 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- 230000007614 genetic variation Effects 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 229940054269 sodium pyruvate Drugs 0.000 description 4
- 241001430294 unidentified retrovirus Species 0.000 description 4
- 210000001325 yolk sac Anatomy 0.000 description 4
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 101000684275 Homo sapiens ADP-ribosylation factor 3 Proteins 0.000 description 3
- 101001130437 Homo sapiens Ras-related protein Rap-2b Proteins 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 102000015696 Interleukins Human genes 0.000 description 3
- 108010063738 Interleukins Proteins 0.000 description 3
- 108091007960 PI3Ks Proteins 0.000 description 3
- 102000038030 PI3Ks Human genes 0.000 description 3
- 102100033810 RAC-alpha serine/threonine-protein kinase Human genes 0.000 description 3
- 102100031421 Ras-related protein Rap-2b Human genes 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 3
- 108010051348 cdc42 GTP-Binding Protein Proteins 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 210000004292 cytoskeleton Anatomy 0.000 description 3
- 238000009795 derivation Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 235000020776 essential amino acid Nutrition 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000009395 genetic defect Effects 0.000 description 3
- 210000004602 germ cell Anatomy 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 238000010874 in vitro model Methods 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 229940047122 interleukins Drugs 0.000 description 3
- 210000004379 membrane Anatomy 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 102000016914 ras Proteins Human genes 0.000 description 3
- 230000001172 regenerating effect Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 230000008672 reprogramming Effects 0.000 description 3
- 102000000568 rho-Associated Kinases Human genes 0.000 description 3
- 108010041788 rho-Associated Kinases Proteins 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000003014 totipotent stem cell Anatomy 0.000 description 3
- 230000002103 transcriptional effect Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 230000014616 translation Effects 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000012583 B-27 Supplement Substances 0.000 description 2
- 108010027344 Basic Helix-Loop-Helix Transcription Factors Proteins 0.000 description 2
- 102000018720 Basic Helix-Loop-Helix Transcription Factors Human genes 0.000 description 2
- 108010001572 Basic-Leucine Zipper Transcription Factors Proteins 0.000 description 2
- 102000000806 Basic-Leucine Zipper Transcription Factors Human genes 0.000 description 2
- 102100023995 Beta-nerve growth factor Human genes 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 101100356682 Caenorhabditis elegans rho-1 gene Proteins 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 241000701022 Cytomegalovirus Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000283073 Equus caballus Species 0.000 description 2
- 102100038595 Estrogen receptor Human genes 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 102100028072 Fibroblast growth factor 4 Human genes 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 101001000061 Homo sapiens Protein phosphatase 1 regulatory subunit 12A Proteins 0.000 description 2
- 102000004232 Mitogen-Activated Protein Kinase Kinases Human genes 0.000 description 2
- 108090000744 Mitogen-Activated Protein Kinase Kinases Proteins 0.000 description 2
- 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 2
- 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 2
- 241001529936 Murinae Species 0.000 description 2
- 239000012580 N-2 Supplement Substances 0.000 description 2
- 108010025020 Nerve Growth Factor Proteins 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- 241000009328 Perro Species 0.000 description 2
- 102100032543 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Human genes 0.000 description 2
- 101710132081 Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN Proteins 0.000 description 2
- 108010038512 Platelet-Derived Growth Factor Proteins 0.000 description 2
- 102000010780 Platelet-Derived Growth Factor Human genes 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 102000001253 Protein Kinase Human genes 0.000 description 2
- 102100036547 Protein phosphatase 1 regulatory subunit 12A Human genes 0.000 description 2
- 101150111584 RHOA gene Proteins 0.000 description 2
- 241000283984 Rodentia Species 0.000 description 2
- 102100038803 Somatotropin Human genes 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 102100031988 Tumor necrosis factor ligand superfamily member 6 Human genes 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 210000003050 axon Anatomy 0.000 description 2
- 239000003181 biological factor Substances 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 230000022131 cell cycle Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000003436 cytoskeletal effect Effects 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000007876 drug discovery Methods 0.000 description 2
- 210000003981 ectoderm Anatomy 0.000 description 2
- 239000002158 endotoxin Substances 0.000 description 2
- 230000008472 epithelial growth Effects 0.000 description 2
- 108010038795 estrogen receptors Proteins 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- 108091006047 fluorescent proteins Proteins 0.000 description 2
- 102000034287 fluorescent proteins Human genes 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical group O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 229960002897 heparin Drugs 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 238000003364 immunohistochemistry Methods 0.000 description 2
- 102000006495 integrins Human genes 0.000 description 2
- 108010044426 integrins Proteins 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229920006008 lipopolysaccharide Polymers 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000003716 mesoderm Anatomy 0.000 description 2
- 238000000386 microscopy Methods 0.000 description 2
- 229940053128 nerve growth factor Drugs 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 230000005937 nuclear translocation Effects 0.000 description 2
- 210000000287 oocyte Anatomy 0.000 description 2
- 102000006271 p21-Activated Kinases Human genes 0.000 description 2
- 108010058266 p21-Activated Kinases Proteins 0.000 description 2
- 102000002574 p38 Mitogen-Activated Protein Kinases Human genes 0.000 description 2
- 108010068338 p38 Mitogen-Activated Protein Kinases Proteins 0.000 description 2
- 210000005059 placental tissue Anatomy 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- -1 poly(ethylene oxide) Polymers 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 108060006633 protein kinase Proteins 0.000 description 2
- 238000001243 protein synthesis Methods 0.000 description 2
- 108010014186 ras Proteins Proteins 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229960001603 tamoxifen Drugs 0.000 description 2
- 230000017423 tissue regeneration Effects 0.000 description 2
- 238000010200 validation analysis Methods 0.000 description 2
- 230000009278 visceral effect Effects 0.000 description 2
- BFOPDSJOLUQULZ-GXKRWWSZSA-N (S)-2-methyl-1-(4-methylisoquinoline-5-sulfonyl)-1,4-diazepane dihydrochloride Chemical compound Cl.Cl.C[C@H]1CNCCCN1S(=O)(=O)C1=CC=CC2=CN=CC(C)=C12 BFOPDSJOLUQULZ-GXKRWWSZSA-N 0.000 description 1
- ILDBNQGLZFSHQZ-UTLKBRERSA-N 2-amino-1-[(3s)-3-methyl-4-(4-methylisoquinolin-5-yl)sulfonyl-1,4-diazepan-1-yl]ethanone;dihydrochloride Chemical compound Cl.Cl.C[C@H]1CN(C(=O)CN)CCCN1S(=O)(=O)C1=CC=CC2=CN=CC(C)=C12 ILDBNQGLZFSHQZ-UTLKBRERSA-N 0.000 description 1
- 108010082078 3-Phosphoinositide-Dependent Protein Kinases Proteins 0.000 description 1
- 102000003737 3-Phosphoinositide-Dependent Protein Kinases Human genes 0.000 description 1
- 102100037263 3-phosphoinositide-dependent protein kinase 1 Human genes 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- XWWFOUVDVJGNNG-UHFFFAOYSA-N 5-(1,4-diazepan-1-ylsulfonyl)-2h-isoquinolin-1-one;hydrochloride Chemical compound Cl.C1=CC=C2C(=O)NC=CC2=C1S(=O)(=O)N1CCCNCC1 XWWFOUVDVJGNNG-UHFFFAOYSA-N 0.000 description 1
- DDLZLOKCJHBUHD-WAVHTBQISA-N 6-bromoindirubin-3'-oxime Chemical compound O=C/1NC2=CC(Br)=CC=C2C\1=C\1/C(=N/O)/C2=CC=CC=C2N/1 DDLZLOKCJHBUHD-WAVHTBQISA-N 0.000 description 1
- 102100040360 Angiomotin Human genes 0.000 description 1
- 108091008875 B cell receptors Proteins 0.000 description 1
- 102000015735 Beta-catenin Human genes 0.000 description 1
- 108060000903 Beta-catenin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 101001110283 Canis lupus familiaris Ras-related C3 botulinum toxin substrate 1 Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- PHEDXBVPIONUQT-UHFFFAOYSA-N Cocarcinogen A1 Natural products CCCCCCCCCCCCCC(=O)OC1C(C)C2(O)C3C=C(C)C(=O)C3(O)CC(CO)=CC2C2C1(OC(C)=O)C2(C)C PHEDXBVPIONUQT-UHFFFAOYSA-N 0.000 description 1
- 241000766026 Coregonus nasus Species 0.000 description 1
- 102000005636 Cyclic AMP Response Element-Binding Protein Human genes 0.000 description 1
- 108010045171 Cyclic AMP Response Element-Binding Protein Proteins 0.000 description 1
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
- 108010036281 Cyclic Nucleotide-Gated Cation Channels Proteins 0.000 description 1
- 102000012003 Cyclic Nucleotide-Gated Cation Channels Human genes 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102100031480 Dual specificity mitogen-activated protein kinase kinase 1 Human genes 0.000 description 1
- 101710146526 Dual specificity mitogen-activated protein kinase kinase 1 Proteins 0.000 description 1
- 101150033452 Elk1 gene Proteins 0.000 description 1
- 102100030751 Eomesodermin homolog Human genes 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 241000272186 Falco columbarius Species 0.000 description 1
- 108010039471 Fas Ligand Protein Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 102100037362 Fibronectin Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102100033067 Growth factor receptor-bound protein 2 Human genes 0.000 description 1
- 108091006065 Gs proteins Proteins 0.000 description 1
- 102000016285 Guanine Nucleotide Exchange Factors Human genes 0.000 description 1
- 108010067218 Guanine Nucleotide Exchange Factors Proteins 0.000 description 1
- 101710103106 Guanine nucleotide-binding protein subunit beta-2-like 1 Proteins 0.000 description 1
- 108010020382 Hepatocyte Nuclear Factor 1-alpha Proteins 0.000 description 1
- 102100022057 Hepatocyte nuclear factor 1-alpha Human genes 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 101000600756 Homo sapiens 3-phosphoinositide-dependent protein kinase 1 Proteins 0.000 description 1
- 101000891154 Homo sapiens Angiomotin Proteins 0.000 description 1
- 101000934426 Homo sapiens Cell division control protein 42 homolog Proteins 0.000 description 1
- 101001064167 Homo sapiens Eomesodermin homolog Proteins 0.000 description 1
- 101000967216 Homo sapiens Eosinophil cationic protein Proteins 0.000 description 1
- 101000871017 Homo sapiens Growth factor receptor-bound protein 2 Proteins 0.000 description 1
- 101000712530 Homo sapiens RAF proto-oncogene serine/threonine-protein kinase Proteins 0.000 description 1
- 101001047642 Homo sapiens Serine/threonine-protein kinase LATS1 Proteins 0.000 description 1
- 101001117146 Homo sapiens [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial Proteins 0.000 description 1
- 238000003744 In vitro fertilisation Methods 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 230000004163 JAK-STAT signaling pathway Effects 0.000 description 1
- 229910013470 LiC1 Inorganic materials 0.000 description 1
- 102000001291 MAP Kinase Kinase Kinase Human genes 0.000 description 1
- 108060006687 MAP kinase kinase kinase Proteins 0.000 description 1
- 229940124647 MEK inhibitor Drugs 0.000 description 1
- 241000282560 Macaca mulatta Species 0.000 description 1
- 102000029749 Microtubule Human genes 0.000 description 1
- 108091022875 Microtubule Proteins 0.000 description 1
- 102100025744 Mothers against decapentaplegic homolog 1 Human genes 0.000 description 1
- 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 1
- 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 1
- 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 1
- 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 1
- 102000007474 Multiprotein Complexes Human genes 0.000 description 1
- 108010085220 Multiprotein Complexes Proteins 0.000 description 1
- OLIIUAHHAZEXEX-UHFFFAOYSA-N N-(6-fluoro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide Chemical compound C1C(=O)NC(C)=C(C(=O)NC=2C(=CC=3NN=CC=3C=2)F)C1C1=CC=C(C(F)(F)F)C=C1 OLIIUAHHAZEXEX-UHFFFAOYSA-N 0.000 description 1
- NPRJSFWNFTXXQC-QFWQFVLDSA-N N-(hexanoyl)sphing-4-enine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCC NPRJSFWNFTXXQC-QFWQFVLDSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 102000001708 Protein Isoforms Human genes 0.000 description 1
- 108010029485 Protein Isoforms Proteins 0.000 description 1
- 102100022309 Protein KIBRA Human genes 0.000 description 1
- 102000002727 Protein Tyrosine Phosphatase Human genes 0.000 description 1
- 101710145046 Protein kibra Proteins 0.000 description 1
- 102100033479 RAF proto-oncogene serine/threonine-protein kinase Human genes 0.000 description 1
- 239000012979 RPMI medium Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 102100034584 Rap guanine nucleotide exchange factor 3 Human genes 0.000 description 1
- 101150114644 Rapgef3 gene Proteins 0.000 description 1
- 101100287693 Rattus norvegicus Kcnh4 gene Proteins 0.000 description 1
- 101100287705 Rattus norvegicus Kcnh8 gene Proteins 0.000 description 1
- 108091005682 Receptor kinases Proteins 0.000 description 1
- 101710203837 Replication-associated protein Proteins 0.000 description 1
- 101150054980 Rhob gene Proteins 0.000 description 1
- 108700010617 S-(1,2,3,4,4-pentachloro-1,3-butadienyl)glutathione Proteins 0.000 description 1
- 101700032040 SMAD1 Proteins 0.000 description 1
- 101150099493 STAT3 gene Proteins 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 102100024031 Serine/threonine-protein kinase LATS1 Human genes 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- 108091008874 T cell receptors Proteins 0.000 description 1
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108010048992 Transcription Factor 4 Proteins 0.000 description 1
- 102100023489 Transcription factor 4 Human genes 0.000 description 1
- 102000000887 Transcription factor STAT Human genes 0.000 description 1
- 108050007918 Transcription factor STAT Proteins 0.000 description 1
- 102100022011 Transcription intermediary factor 1-alpha Human genes 0.000 description 1
- 101710139186 Transcription intermediary factor 1-alpha Proteins 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 108050002568 Tumor necrosis factor ligand superfamily member 6 Proteins 0.000 description 1
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 1
- KLGQSVMIPOVQAX-UHFFFAOYSA-N XAV939 Chemical compound N=1C=2CCSCC=2C(O)=NC=1C1=CC=C(C(F)(F)F)C=C1 KLGQSVMIPOVQAX-UHFFFAOYSA-N 0.000 description 1
- IYOZTVGMEWJPKR-IJLUTSLNSA-N Y-27632 Chemical compound C1C[C@@H]([C@H](N)C)CC[C@@H]1C(=O)NC1=CC=NC=C1 IYOZTVGMEWJPKR-IJLUTSLNSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- HSROPTGRSYJPJY-JZGIKJSDSA-N [2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-7-yl]-[(3s)-3-aminopyrrolidin-1-yl]methanone;dihydrochloride Chemical compound Cl.Cl.C=12N(CC)C(C=3C(=NON=3)N)=NC2=CN=CC=1C(=O)N1CC[C@H](N)C1 HSROPTGRSYJPJY-JZGIKJSDSA-N 0.000 description 1
- 108010023082 activin A Proteins 0.000 description 1
- 102000030621 adenylate cyclase Human genes 0.000 description 1
- 108060000200 adenylate cyclase Proteins 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 208000036878 aneuploidy Diseases 0.000 description 1
- 230000033115 angiogenesis Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000012237 artificial material Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000023402 cell communication Effects 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 230000023715 cellular developmental process Effects 0.000 description 1
- 230000004640 cellular pathway Effects 0.000 description 1
- 230000033077 cellular process Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000030944 contact inhibition Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000011557 critical solution Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 102000003675 cytokine receptors Human genes 0.000 description 1
- 108010057085 cytokine receptors Proteins 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 210000003785 decidua Anatomy 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000006471 dimerization reaction Methods 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000009509 drug development Methods 0.000 description 1
- 239000003596 drug target Substances 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 230000008995 epigenetic change Effects 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000646 extraembryonic cell Anatomy 0.000 description 1
- 229960002435 fasudil Drugs 0.000 description 1
- NGOGFTYYXHNFQH-UHFFFAOYSA-N fasudil Chemical compound C=1C=CC2=CN=CC=C2C=1S(=O)(=O)N1CCCNCC1 NGOGFTYYXHNFQH-UHFFFAOYSA-N 0.000 description 1
- 210000004420 female germ cell Anatomy 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 210000001650 focal adhesion Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000003869 genetically modified organism Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000006801 homologous recombination Effects 0.000 description 1
- 238000002744 homologous recombination Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010166 immunofluorescence Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000003794 male germ cell Anatomy 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 210000004688 microtubule Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 238000003032 molecular docking Methods 0.000 description 1
- 239000003147 molecular marker Substances 0.000 description 1
- 210000002198 morula cell Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- INVVXEKRUDMEBE-UHFFFAOYSA-N n-[2-[2-(dimethylamino)ethoxy]-4-(1h-pyrazol-4-yl)phenyl]-2,3-dihydro-1,4-benzodioxine-3-carboxamide;dihydrochloride Chemical compound Cl.Cl.C=1C=C(NC(=O)C2OC3=CC=CC=C3OC2)C(OCCN(C)C)=CC=1C=1C=NNC=1 INVVXEKRUDMEBE-UHFFFAOYSA-N 0.000 description 1
- YOVNFNXUCOWYSG-UHFFFAOYSA-N n-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide Chemical compound C1=C2N(CC)C(C=3C(=NON=3)N)=NC2=CN=C1OC(C=1)=CC=CC=1NC(=O)C(C=C1)=CC=C1OCCN1CCOCC1 YOVNFNXUCOWYSG-UHFFFAOYSA-N 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000008779 noncanonical pathway Effects 0.000 description 1
- 235000021231 nutrient uptake Nutrition 0.000 description 1
- 238000006384 oligomerization reaction Methods 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007310 pathophysiology Effects 0.000 description 1
- PHEDXBVPIONUQT-RGYGYFBISA-N phorbol 13-acetate 12-myristate Chemical compound C([C@]1(O)C(=O)C(C)=C[C@H]1[C@@]1(O)[C@H](C)[C@H]2OC(=O)CCCCCCCCCCCCC)C(CO)=C[C@H]1[C@H]1[C@]2(OC(C)=O)C1(C)C PHEDXBVPIONUQT-RGYGYFBISA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000000865 phosphorylative effect Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920003213 poly(N-isopropyl acrylamide) Polymers 0.000 description 1
- 229920000098 polyolefin Polymers 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 108020001775 protein parts Proteins 0.000 description 1
- 108020000494 protein-tyrosine phosphatase Proteins 0.000 description 1
- 230000007115 recruitment Effects 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 108010033674 rho GTP-Binding Proteins Proteins 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000024642 stem cell division Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 210000003518 stress fiber Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000001608 teratocarcinoma Diseases 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000002463 transducing effect Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000005945 translocation Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 210000000143 trophectoderm cell Anatomy 0.000 description 1
- 102000003390 tumor necrosis factor Human genes 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B17/425—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation
- A61B17/435—Gynaecological or obstetrical instruments or methods for reproduction or fertilisation for embryo or ova transplantation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0604—Whole embryos; Culture medium therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0697—Artificial constructs associating cells of different lineages, e.g. tissue equivalents
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/44—Thiols, e.g. mercaptoethanol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/01—Modulators of cAMP or cGMP, e.g. non-hydrolysable analogs, phosphodiesterase inhibitors, cholera toxin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/105—Insulin-like growth factors [IGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/119—Other fibroblast growth factors, e.g. FGF-4, FGF-8, FGF-10
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/15—Transforming growth factor beta (TGF-β)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/20—Cytokines; Chemokines
- C12N2501/23—Interleukins [IL]
- C12N2501/235—Leukemia inhibitory factor [LIF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
- C12N2501/392—Sexual steroids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/40—Regulators of development
- C12N2501/415—Wnt; Frizzeled
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
- C12N2501/72—Transferases (EC 2.)
- C12N2501/727—Kinases (EC 2.7.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
- C12N2501/91—Heparin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2502/00—Coculture with; Conditioned medium produced by
- C12N2502/02—Coculture with; Conditioned medium produced by embryonic cells
- C12N2502/025—Coculture with; Conditioned medium produced by embryonic cells extra-embryonic cells, e.g. amniotic epithelium, placental cells, Wharton's jelly
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2531/00—Microcarriers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Cell Biology (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Transplantation (AREA)
- Pregnancy & Childbirth (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13164018 | 2013-04-16 | ||
EP13164018.7 | 2013-04-16 | ||
PCT/NL2014/050239 WO2014171824A1 (en) | 2013-04-16 | 2014-04-16 | Blastoid, cell line based artificial blastocyst |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2908443A1 true CA2908443A1 (en) | 2014-10-23 |
Family
ID=48092839
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2908443A Abandoned CA2908443A1 (en) | 2013-04-16 | 2014-04-16 | Blastoid, cell line based artificial blastocyst |
Country Status (6)
Country | Link |
---|---|
US (1) | US9822336B2 (ja) |
EP (1) | EP2986711A1 (ja) |
JP (1) | JP6689498B2 (ja) |
CN (1) | CN105683363A (ja) |
CA (1) | CA2908443A1 (ja) |
WO (1) | WO2014171824A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2908443A1 (en) | 2013-04-16 | 2014-10-23 | Koninklijke Nederlandse Akademie Van Wetenschappen | Blastoid, cell line based artificial blastocyst |
CN111793608B (zh) * | 2017-07-28 | 2022-05-17 | 杨涛 | 定向诱导hiPSC分化为神经细胞体系的HS5条件培养基 |
CN108913654B (zh) * | 2018-07-06 | 2022-08-05 | 南宁市第二人民医院 | Hippo-YAP通路与Wnt通路相互作用在脂肪干细胞细胞谱命运选择中的用途 |
WO2021067854A1 (en) * | 2019-10-03 | 2021-04-08 | Salk Institute For Biological Studies | Blastocyst-like structures from extended pluripotent stem cells |
WO2021079992A1 (ja) * | 2019-10-25 | 2021-04-29 | 国立大学法人京都大学 | 多能性幹細胞からの胚盤胞様構造体の作製法 |
JP2023550180A (ja) * | 2020-11-24 | 2023-11-30 | モナシュ ユニバーシティ | 誘導幹細胞 |
JPWO2022114188A1 (ja) * | 2020-11-30 | 2022-06-02 | ||
EP4029932A1 (en) | 2021-01-13 | 2022-07-20 | IMBA-Institut für Molekulare Biotechnologie GmbH | Blastocyst-like cell aggregate and methods |
WO2022152774A1 (en) | 2021-01-13 | 2022-07-21 | Imba - Institut Für Molekulare Biotechnologie Gmbh | Blastocyst-like cell aggregate and methods |
CN112831461B (zh) * | 2021-02-26 | 2023-08-08 | 澳门大学 | 一种诱导干细胞分化成中胚层谱系或滋养细胞谱系的方法及药物 |
CN113201500A (zh) * | 2021-05-07 | 2021-08-03 | 华夏源细胞工程集团股份有限公司 | 一种培养iPS细胞的无滋养层培养基 |
TW202328432A (zh) * | 2021-08-26 | 2023-07-16 | 清華大學 | 誘導全能性幹細胞及其製備方法 |
WO2024030443A1 (en) * | 2022-08-01 | 2024-02-08 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Bovine blastocyst like structures and uses thereof |
CN115927168A (zh) * | 2023-01-13 | 2023-04-07 | 广州国家实验室 | 全能样细胞高效产生类囊胚的方法及其应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1802193E (pt) * | 2004-10-19 | 2014-06-23 | Regeneron Pharma | Método para gerar um murganho homozigótico para uma modificação genética |
CA2679109C (en) * | 2007-02-23 | 2016-07-19 | Advanced Cell Technology, Inc. | Derivation of embryonic stem cells |
EP2088191A1 (en) | 2008-02-08 | 2009-08-12 | Rheinische Friedrich-Wilhelms-Universität Bonn | Induced blastocyst-like structures, methods of production and uses of the same |
EP2408903B1 (en) | 2009-03-20 | 2014-08-06 | Agency For Science, Technology And Research | Culture of pluripotent and multipotent cells on microcarriers |
DK2582794T3 (en) * | 2010-06-15 | 2018-05-22 | Cellular Dynamics Int Inc | GENERATION OF INDUCED PLURIPOTENT STEM CELLS FROM SMALL VOLUMES OF PERIPHERAL BLOOD |
US20130074200A2 (en) | 2011-01-21 | 2013-03-21 | Cold Spring Harbor Laboratory | Inbred c57bl/6 es cells with high developmental capacity |
JPWO2012117968A1 (ja) | 2011-02-28 | 2014-07-07 | 学校法人 岩手医科大学 | 胚の発生および/または分化を制御する方法 |
CA2908443A1 (en) | 2013-04-16 | 2014-10-23 | Koninklijke Nederlandse Akademie Van Wetenschappen | Blastoid, cell line based artificial blastocyst |
-
2014
- 2014-04-16 CA CA2908443A patent/CA2908443A1/en not_active Abandoned
- 2014-04-16 JP JP2016508921A patent/JP6689498B2/ja active Active
- 2014-04-16 WO PCT/NL2014/050239 patent/WO2014171824A1/en active Application Filing
- 2014-04-16 US US14/784,659 patent/US9822336B2/en not_active Expired - Fee Related
- 2014-04-16 CN CN201480028434.0A patent/CN105683363A/zh active Pending
- 2014-04-16 EP EP14721550.3A patent/EP2986711A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2014171824A1 (en) | 2014-10-23 |
JP6689498B2 (ja) | 2020-04-28 |
US9822336B2 (en) | 2017-11-21 |
CN105683363A (zh) | 2016-06-15 |
US20160060593A1 (en) | 2016-03-03 |
JP2016518831A (ja) | 2016-06-30 |
EP2986711A1 (en) | 2016-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9822336B2 (en) | Blastoid, cell line based artificial blastocyst | |
Dong et al. | Derivation of trophoblast stem cells from naïve human pluripotent stem cells | |
De Paepe et al. | Totipotency and lineage segregation in the human embryo | |
CN108884436B (zh) | 诱导的扩展的多潜能干细胞、制备及使用方法 | |
Correia et al. | Regulation and roles of Ca2+ stores in human sperm | |
Saiz et al. | Early cell fate decisions in the mouse embryo | |
Pera et al. | The exploration of pluripotency space: Charting cell state transitions in peri-implantation development | |
Mackinlay et al. | An in vitro stem cell model of human epiblast and yolk sac interaction | |
KR20180135482A (ko) | 망막 조직의 제조 방법 | |
CN108934168A (zh) | 用于将非多能细胞重编程为多能干细胞的改进方法 | |
KR20180079302A (ko) | 시원 생식 세포를 기능적으로 성숙한 난모 세포로 분화시키는 배양 방법 | |
US20200283735A1 (en) | Organoid and method for producing the same | |
Stower et al. | The head's tale: anterior-posterior axis formation in the mouse embryo | |
Harrison et al. | In vitro generation of mouse polarized embryo-like structures from embryonic and trophoblast stem cells | |
US20210189330A1 (en) | Induced totipotent stem cells and methods for making and using the same | |
Yang et al. | In vitro establishment of expanded-potential stem cells from mouse pre-implantation embryos or embryonic stem cells | |
KR20210049779A (ko) | 장관 신경전구세포의 제조 방법 | |
WO2021049613A1 (ja) | 未成熟卵母細胞の誘導方法及び成熟卵母細胞の作製方法 | |
Heidari Khoei et al. | Generating human blastoids modeling blastocyst-stage embryos and implantation | |
WO2015125926A1 (ja) | 栄養膜幹細胞の樹立及び維持方法 | |
Zhang et al. | Human embryoids: A new strategy of recreating the first steps of embryonic development in vitro | |
Menchero et al. | Our first choice: cellular and genetic underpinnings of trophectoderm identity and differentiation in the mammalian embryo | |
US20220228111A1 (en) | Nociceptor differentiation from human pluripotent stem cells | |
Du et al. | In vitro spermatogenesis from pluripotent stem cells | |
WO2024030443A1 (en) | Bovine blastocyst like structures and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20190402 |
|
FZDE | Discontinued |
Effective date: 20210831 |